is the most common chronic MSK condition in children and the most common cause of MSK disability.
Now Jordy himself is launching a support group called Arthritis Kids Unite to raise awareness of JIA
and raise money for Arthritis Research UK.
The new GT has been made possible thanks to an agreement between JIA
and Jensen Motor Group, which now owns the Jensen name.
outcome measures have been validated and are now widely used in clinical trials, including the ACR Pedi 30/50/70.
group was comprised of children diagnosed with JIA
at the Capital Institute of Pediatrics between February 2009 and December 2009.
is a form of inflammatory joint disease that affects around 15,000 children in the UK.
Eighty-two of the patients had JIA
and 35 patients had FMF.
In contrast to a typical RA patient with other co-existing disease, children with JIA
have less co-morbidity, and may, therefore, better tolerate medications.
While there are a number of effective therapies available for JIA
, interviewed thought leaders are calling for the implementation of approaches that would improve treatment efficacy, including increased emphasis on patient-reported outcomes and availability of biomarkers to guide personalized therapy.
The drugs used in the treatment of JIA
are identical to those used in adult rheumatic diseases.
is a general term used to describe the various chronic arthritis diseases in children.
As with most classification criteria in rheumatology, the diagnosis of JIA
is one of exclusion, obligating the clinician to rule out rheumatic, infectious, and other potential causes of chronic synovitis.